Control of the same sample. Panel C shows an overview of

Control of the same sample. Panel C shows an overview of a colorectal adenoma with adjacent normal colonic mucosa. C1 and C2 correspond to the indicated areas in panel C and show normal colonic mucosa with normal E-cadherin staining (C1) and colorectal adenoma with reduced E-cadherin staining (C2). doi:10.1371/journal.pone.0046665.gFigure 5. Snail1 expression in normal colonic mucosa and colorectal adenoma. Expression of Snail1 was determined as indicated in Methods using Ab17732 antibody as positive and X0903 antibody as negative control. Panels A and B show corresponding areas of a colorectal adenoma. Panel A corresponds to Snail1 staining (arrows = Snail1 positive cells), while panel B shows the negative control. A1: adenomatous tissue negative for Snail1 staining. A2: colorectal adenoma tissue positive for nuclear Snail1 staining Panels B1 and B2: no positive reaction in negative control. doi:10.1371/journal.pone.0046665.gimmunohistochemistry, we could observe a trend towards a correlation between a nuclear Snail1 staining and lower Ecadherin protein expression (p = 0.095, Mann-Whitney-U test) (Fig. 8).DiscussionIt has been clearly shown in a variety of model systems that cancer cells use EMT to down-regulate their cell-cell contacts and to become motile and invasive [5]. Many authors regard EMT as a major mechanism enabling metastasis and initiating the transition between benign and malignant disease. Consequently, one would not expect frequent expression of EMT master regulators in benign tumors. Analysing an unselected cohort of colorectal adenomas, we were therefore surprised by the relatively high frequency of SNAI1 and TWIST1 mRNA expression, which was quite similar to the published expression rates in CRC tissue. The previously reported expression rates in CRC were 50?8 for SNAI1 [9] and 40 ?0 for TWIST1 [8,10,13], respectively.In contrast, and as expected, SNAI1 and TWIST1 mRNAs were not PS 1145 detected in morphologically normal colon mucosa by our qRT-PCR assay. Strikingly, mRNA expression of SNAI1 was significantly correlated with decreased levels of CDH1 mRNA in colorectal adenomas, suggesting an “active” CDH1 suppression by the transcription factor SNAI1. Although the correlation between TWIST1 expression and CDH1 levels did not reach statistical significance, a lower mean CDH1 level was noted for TWIST1 positive adenomas. For our qPCR-assay we used primers and probes published by Rosivatz et al. [18], which were tested for FFPE samples. As in our current study on colorectal adenoma tissue, they observed in diffuse gastric cancer that increased SNAI1 mRNA expression was associated with down-regulation of CDH1 mRNA [18]. However, when they applied their qPCR assay to 16 CRC they did not observe TWIST1 expression and SNAI1 was only rarely detected in 31 investigated CRC tissues [23]. A possible explanation for this discrepancy to our data might be a higher sensitivity of the qPCR assay used by us due to the different chemistry and set-up of the assay. However, the expression frequencies of SNAI1 and TWIST1 observed in our study are in line with protein/mRNA expression data in CRC on these transcription factors that have been published within the last five years [8,9,10,13]. To obtain further validation of our mRNA expression data, we wanted to compare the mRNA data with the protein expression directly. This was possible on the remaining FFPE material of the same tissue block. We Dimethylenastron site focused our validation study on the protein lev.Control of the same sample. Panel C shows an overview of a colorectal adenoma with adjacent normal colonic mucosa. C1 and C2 correspond to the indicated areas in panel C and show normal colonic mucosa with normal E-cadherin staining (C1) and colorectal adenoma with reduced E-cadherin staining (C2). doi:10.1371/journal.pone.0046665.gFigure 5. Snail1 expression in normal colonic mucosa and colorectal adenoma. Expression of Snail1 was determined as indicated in Methods using Ab17732 antibody as positive and X0903 antibody as negative control. Panels A and B show corresponding areas of a colorectal adenoma. Panel A corresponds to Snail1 staining (arrows = Snail1 positive cells), while panel B shows the negative control. A1: adenomatous tissue negative for Snail1 staining. A2: colorectal adenoma tissue positive for nuclear Snail1 staining Panels B1 and B2: no positive reaction in negative control. doi:10.1371/journal.pone.0046665.gimmunohistochemistry, we could observe a trend towards a correlation between a nuclear Snail1 staining and lower Ecadherin protein expression (p = 0.095, Mann-Whitney-U test) (Fig. 8).DiscussionIt has been clearly shown in a variety of model systems that cancer cells use EMT to down-regulate their cell-cell contacts and to become motile and invasive [5]. Many authors regard EMT as a major mechanism enabling metastasis and initiating the transition between benign and malignant disease. Consequently, one would not expect frequent expression of EMT master regulators in benign tumors. Analysing an unselected cohort of colorectal adenomas, we were therefore surprised by the relatively high frequency of SNAI1 and TWIST1 mRNA expression, which was quite similar to the published expression rates in CRC tissue. The previously reported expression rates in CRC were 50?8 for SNAI1 [9] and 40 ?0 for TWIST1 [8,10,13], respectively.In contrast, and as expected, SNAI1 and TWIST1 mRNAs were not detected in morphologically normal colon mucosa by our qRT-PCR assay. Strikingly, mRNA expression of SNAI1 was significantly correlated with decreased levels of CDH1 mRNA in colorectal adenomas, suggesting an “active” CDH1 suppression by the transcription factor SNAI1. Although the correlation between TWIST1 expression and CDH1 levels did not reach statistical significance, a lower mean CDH1 level was noted for TWIST1 positive adenomas. For our qPCR-assay we used primers and probes published by Rosivatz et al. [18], which were tested for FFPE samples. As in our current study on colorectal adenoma tissue, they observed in diffuse gastric cancer that increased SNAI1 mRNA expression was associated with down-regulation of CDH1 mRNA [18]. However, when they applied their qPCR assay to 16 CRC they did not observe TWIST1 expression and SNAI1 was only rarely detected in 31 investigated CRC tissues [23]. A possible explanation for this discrepancy to our data might be a higher sensitivity of the qPCR assay used by us due to the different chemistry and set-up of the assay. However, the expression frequencies of SNAI1 and TWIST1 observed in our study are in line with protein/mRNA expression data in CRC on these transcription factors that have been published within the last five years [8,9,10,13]. To obtain further validation of our mRNA expression data, we wanted to compare the mRNA data with the protein expression directly. This was possible on the remaining FFPE material of the same tissue block. We focused our validation study on the protein lev.